Propanc Biopharma, Inc. Common Stock (PPCB) — Capital Reinvestment Ratio

Latest as of December 2024: 0.00x

Propanc Biopharma, Inc. Common Stock (PPCB) has a Capital Reinvestment Ratio of 0.00x as of December 2024, meaning it reinvests 0% of its operating cash flow ($18.73K) in capital expenditures ($4.87). See Propanc Biopharma, Inc. Common Stock free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

$18.73K

USD

Capital Expenditures

$4.87

USD

Data as of

Dec 2024

Most recent filing

Annual Capital Reinvestment Ratio for Propanc Biopharma, Inc. Common Stock (None–None)

Year-by-year Capital Reinvestment Ratio for Propanc Biopharma, Inc. Common Stock from None to None. For live market cap and broader valuation context, see Propanc Biopharma, Inc. Common Stock stock valuation.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow